Between non-obese and obese NAFLD patients, there was no significant difference in the prevalence of diabetes, haemoglobin, platelet count, TB, AST, albumin, fasting plasma glucose, HbA1C, and lipids. This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.